Your session is about to expire
What is Cedax
Approved as Treatment by the FDA
Ceftibuten, also called Cedax, is approved by the FDA for 5 uses including Bronchitis, Chronic and Tonsillitis .Effectiveness
When to interrupt dosage
The prescribed dosage of Cedax is contingent upon the identified condition, such as Sinusitis, Bacterial Pneumonia and Urinary tract infection. The amount of dosage is contingent upon the type of administration (e.g. Suspension - Oral or Suspension) specified in the table below.Warnings
Cedax has one contraindication and should not be administered when presenting with any of the conditions stated in the table below.Cedax ContraindicationsCedax Novel Uses: Which Conditions Have a Clinical Trial Featuring Cedax?
143 active clinical trials are currently assessing the potential of Cedax to mitigate Upper Respiratory Infections, Tonsillitis and Urinary Tract Infection (UTI).Cedax Reviews: What are patients saying about Cedax?
Patient Q&A Section about cedax
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.What is the generic name for Cedax?
"The oral form of this medication is used to treat certain types of skin infections (e.g., cellulitis, folliculitis, impetigo).
This drug is used to treat certain types of skin infections, including cellulitis, folliculitis, and impetigo."
What is Cedax used for?
"It will not work for viral infections (such as common cold, flu).
Ceftibuten is used for treating a variety of bacterial infections. It is a cephalosporin antibiotic, which works by stopping the growth of bacteria. It is only effective against bacterial infections, and not viral infections."
What is the contraindications for Cedax?
"You may experience diarrhea from an infection with Clostridium difficile bacteria, as well as inflammation of the large intestine. If you have moderate to severe kidney impairment, these conditions may be exacerbated."
Why was Cedax discontinued?
"The reason for the discontinuation of Cedax (ceftibuten) is unknown. In 2017, the FDA found that there were no safety or effectiveness issues with the suspension form of the medication."